IWM vs XBI

iShares Russell 2000 ETF vs SPDR S&P Biotech ETF

Quick take
  • • IWM has the lower expense ratio at 0.19% vs 0.35% for XBI.
  • • IWM pays a higher dividend yield (0.98%).

Side-by-side metrics

MetricIWMXBI
Expense ratio
Annual fee. Lower is better.
0.19%0.35%
Dividend yield
Trailing 12-month yield.
0.98%0.35%
AUM
Assets under management — bigger funds are typically more liquid.
$75.49B$10.92B
YTD return
15.54%28.80%
1-year return
——
3-year return
Annualized.
——
5-year return
Annualized.
——
10-year return
Annualized.
——
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
1.261.01
P/E ratio
16.52—
Last price
$283.55$156.41
Inception
——
Issuer
iSharesState Street

IWM top holdings

Top holdings · IWM
GKOSGlaukos Corp0.46%
BTSGBrightSpring Health Services Inc0.38%
FROGJFrog Ltd Ordinary Shares0.35%
TWSTTwist Bioscience Corp0.34%
MOG-AMoog Inc Class A0.34%
UMBFUMB Financial Corp0.33%
VSATViasat Inc0.33%
SMSM Energy Co0.33%
EATBrinker International Inc0.31%
RHPRyman Hospitality Properties Inc0.30%
Sector breakdown · IWM
Real Estate6.5%
Consumer Cyclical9.1%
Basic Materials4.1%
Consumer Defensive2.6%
Technology14.0%
Communication Services2.2%
Financial Services18.2%
Utilities2.8%
Industrials12.7%
Energy6.8%
Healthcare21.0%

XBI top holdings

Top holdings · XBI
MRNAModerna Inc2.37%
NTRANatera Inc1.82%
HALOHalozyme Therapeutics Inc1.77%
TWSTTwist Bioscience Corp1.77%
BIIBBiogen Inc1.75%
AMGNAmgen Inc1.73%
EXELExelixis Inc1.73%
UTHRUnited Therapeutics Corp1.72%
ABBVAbbVie Inc1.71%
GILDGilead Sciences Inc1.70%
Sector breakdown · XBI
Financial Services0.6%
Healthcare99.3%

About IWM

IWM (iShares Russell 2000 ETF) is US small-cap stocks (Russell 2000). Managed by iShares, the fund carries $75.5B in assets under management, an expense ratio of 0.19%, a dividend yield of 0.98%. Its largest holding is Glaukos Corp (GKOS), which represents 0.5% of the portfolio. Real Estate is the fund's largest sector exposure at 6.5%.

About XBI

XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.